Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:49 PM
Ignite Modification Date: 2025-12-24 @ 5:49 PM
NCT ID: NCT03962868
Eligibility Criteria: Inclusion Criteria: * Patient suffering from non-pedunculated polyp suspected larger than 25 mm in the colon * Colon localization beyond 15 cm of the anal margin. * Indication for endoscopic treatment * Patients aged ≥ 18 years old * Patients able to fill in questionnaires written in French Exclusion Criteria: * Prior endoscopic resection attempt * Contra-indication to colonoscopy * Contra-indication to general anesthesia * Inability to stop antiplatelet agents and anti-coagulant according to the European Society of Gastro-Intestinal Endoscopy guidelines. * Recurrent adenoma: post-endoscopic or surgical resection * Pregnant or lactating women * Genetic polyposis (Familial Adenomatous Polyposis, Lynch Syndrome, Peutz-Jeghers Syndrome) * Inability to provide informed consent * Patient under legal protection and or deprived of liberty by judicial or administrative decision * Patient already participating in an interventional clinical research protocol * Patient who cannot be followed for the duration of the study * Non-pedunculated polyp ≤ 25 mm * More than one lesion \> 25 mm that fulfilled the inclusion criteria * Suspicion of deep submucosal cancer by analysis of macroscopic appearance (Paris 0-III), vascular pattern and pit pattern (SANO IIIB, KUDO Vn) * Non granular pseudodepressed Laterally spreading tumors due to the high risk of nonvisible submucosal cancer * Polyp involving the appendice deeply (type 2 or 3 of classification of Toyonaga) * Polyp inside the ileo-caecal valvula * Tattoing under the lesionInflammatory Bowel Disease with expected fibrosis (Crohn disease or ulcerative colitis) * Colon localization \< 15 cm of the anal margin. * Polyp invading a diverticulum * Pedunculated polyp * Absence of lesion
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT03962868
Study Brief:
Protocol Section: NCT03962868